PTCL
Clinical trials for PTCL explained in plain language.
Never miss a new study
Get alerted when new PTCL trials appear
Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New nanobody CAR-T therapy takes on tough T-Cell cancers
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy that uses nanobodies to target a protein called CD5 on cancer cells. It is for people aged 3 to 70 with T-cell acute lymphoblastic leukemia or T-cell lymphoma that has come back or not responded to other treatments. The goal is to…
Matched conditions: PTCL
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
New drug cocktail aims to control rare blood cancer in relapsed patients
Disease control Recruiting nowThis study is for people with a rare type of blood cancer called peripheral T-cell lymphoma (PTCL) that has returned or not responded to prior therapy. It tests whether taking two drugs together (oral azacytidine and romidepsin) is better than taking one of several standard singl…
Matched conditions: PTCL
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 14, 2026 12:05 UTC